Direkt zum Inhalt
Merck

Characterization of a novel RP2-OSTF1 interaction and its implication for actin remodelling.

Journal of cell science (2018-01-24)
Rodanthi Lyraki, Mandy Lokaj, Dinesh C Soares, Abigail Little, Matthieu Vermeren, Joseph A Marsh, Alfred Wittinghofer, Toby Hurd
ZUSAMMENFASSUNG

Retinitis pigmentosa 2 (RP2) is the causative gene for a form of X-linked retinal degeneration. RP2 was previously shown to have GTPase-activating protein (GAP) activity towards the small GTPase ARL3 via its N-terminus, but the function of the C-terminus remains elusive. Here, we report a novel interaction between RP2 and osteoclast-stimulating factor 1 (OSTF1), an intracellular protein that indirectly enhances osteoclast formation and activity and is a negative regulator of cell motility. Moreover, this interaction is abolished by a human pathogenic mutation in RP2. We utilized a structure-based approach to pinpoint the binding interface to a strictly conserved cluster of residues on the surface of RP2 that spans both the C- and N-terminal domains of the protein, and which is structurally distinct from the ARL3-binding site. In addition, we show that RP2 is a positive regulator of cell motility in vitro, recruiting OSTF1 to the cell membrane and preventing its interaction with the migration regulator Myo1E.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Monoklonaler Anti-Aktin-Antikörper der Maus, clone AC-40, purified from hybridoma cell culture
Sigma-Aldrich
Anti-Integrin-beta-1-Antikörper, zytosolisch, serum, Chemicon®